PG
51
-2
MAR
50
3
VZ
45
-2
SWK
80
2
GT
46
3
CI
66
-2
ICE
64
-5
MA
65
-4
MRK
53
3
FLS
46
-7
WDC
49
-3
SPG
53
-2
AAL
47
-3
NSC
62
2
DOV
63
-6
GE
85
3
SE
65
4
ADSK
65
-2
HUM
30
3
LYB
44
-2
PG
51
-2
MAR
50
3
VZ
45
-2
SWK
80
2
GT
46
3
CI
66
-2
ICE
64
-5
MA
65
-4
MRK
53
3
FLS
46
-7
WDC
49
-3
SPG
53
-2
AAL
47
-3
NSC
62
2
DOV
63
-6
GE
85
3
SE
65
4
ADSK
65
-2
HUM
30
3
LYB
44
-2
Financhill
Back

Repligen Vs. Biomarin Pharmaceutical Industry Stock Comparison

Buy
58

RGEN
Repligen

Last Price:
147.34
Seasonality Move:
-3.11%
Sell
33

BMRN
Biomarin Pharmaceutical

Last Price:
71.41
Seasonality Move:
5.7%
Buy
58
Repligen (RGEN) is a Buy

Is Repligen a Buy, Sell or Hold?

  • The current Repligen [RGEN] share price is $142.10. The Score for RGEN is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
  • RGEN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
33
Biomarin Pharmaceutical (BMRN) is a Sell

Is Biomarin Pharmaceutical a Buy, Sell or Hold?

  • The current Biomarin Pharmaceutical [BMRN] share price is $71.14. The Score for BMRN is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
  • BMRN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

RGEN Stock Price Chart

What is Repligen's stock price today?

  • The Repligen share price today is $142.10
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RGEN is experiencing buying pressure, which is a positive indicator for future bullish movement.

BMRN Stock Price Chart

What is Biomarin Pharmaceutical's stock price today?

  • The Biomarin Pharmaceutical share price today is $71.14
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMRN is experiencing slight buying pressure.

RGEN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.5 Sell
Relative Strength Index (14 RSI): 45.74 Sell
Chaikin Money Flow: 433944 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (141.15 - 152.93) Sell
Bollinger Bands (100): (130.24 - 163.08) Sell

BMRN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.61 Sell
Relative Strength Index (14 RSI): 22.64 Sell
Chaikin Money Flow: 871265 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (80.02 - 93.28) Sell
Bollinger Bands (100): (78.57 - 88.29) Sell

RGEN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 141.87 Buy
20-day SMA: 145.06 Sell
50-day SMA: 145.99 Sell
200-day SMA: 164.85 Sell
8-day EMA: 141.63 Buy
20-day EMA: 144.73 Sell
50-day EMA: 146.21 Sell
200-day EMA: 156.61 Sell

BMRN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 79.35 Sell
20-day SMA: 85.57 Sell
50-day SMA: 85.93 Sell
200-day SMA: 87.02 Sell
8-day EMA: 77.71 Sell
20-day EMA: 82.86 Sell
50-day EMA: 84.86 Sell
200-day EMA: 86.16 Sell

Repligen Earnings Growth & RGEN Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.17 per share, an increase next quarter of $0.13 per share, a decrease this year of $0.29 per share, and an increase next year of $0.46 per share.

Biomarin Pharmaceutical Earnings Growth & BMRN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.31 per share, an increase next quarter of $0.29 per share, an increase this year of $1.19 per share, and an increase next year of $1.04 per share.

Repligen Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Biomarin Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):